retatrutide trial weight loss (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Eli Lilly's Next-Gen Obesity Drug

These actions occur continuously once therapeutic levels are established, regardless of when the injection is administered

Researchers planning longer-term protocols might benefit from purchasing supplies before this anticipated price pressure builds

Vallf, D., Kalafateli, A

GLP-1 agonist medications can change how some medicines work, and other medicines may affect how GLP-1 medications work too

About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them about 6% of adults, or more than 15 million people are currently using a prescription, according to new survey data from KFF

Doing this can help you sleep through unwanted side effects so you feel better when you wake up